Cargando…

ProLonged Liposomal Delivery of TLR7/8 Agonist for Enhanced Cancer Vaccine

Despite numerous studies on cancer treatment, cancer remains a challenging disease to cure, even after decades of research. In recent years, the cancer vaccine has emerged as a promising approach for cancer treatment, offering few unexpected side effects compared to existing therapies. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Sehui, Park, Yeji, Kim, Jeonghun, Kim, Sohyun, Choi, Kyungmin, Kang, Taegyun, Lee, Inho, Lim, Yong Taik, Um, Soong Ho, Kim, Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538091/ https://www.ncbi.nlm.nih.gov/pubmed/37766179 http://dx.doi.org/10.3390/vaccines11091503

Ejemplares similares

The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes
por: Wui, Seo Ri, et al.
Publicado: (2021)

Bead-Immobilized Multimodal Molecular Beacon-Equipped DNA Machinery for Specific RNA Target Detection: A Prototypical Molecular Nanobiosensor
por: Kim, Jeonghun, et al.
Publicado: (2021)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Gold nanoparticle clusters for the investigation of therapeutic efficiency against prostate cancer under near-infrared irradiation
por: Kim, Jeonghun, et al.
Publicado: (2020)

Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
por: Jensen, Simon S, et al.
Publicado: (2013)

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
por: Gadd, Adam J.R., et al.
Publicado: (2018)

Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
por: Wheat, William, et al.
Publicado: (2019)

A novel defined TLR3 agonist as an effective vaccine adjuvant
por: Ko, Kwang Hyun, et al.
Publicado: (2023)

Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery
por: Chen, Xiaoyu, et al.
Publicado: (2012)

Pharmacological Activation of p53 during Human Monocyte to Macrophage Differentiation Attenuates Their Pro-Inflammatory Activation by TLR4, TLR7 and TLR8 Agonists
por: Namgaladze, Dmitry, et al.
Publicado: (2021)

Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE(2) Production
por: Lee, Jinhee, et al.
Publicado: (2015)

Therapeutic Applications of the CRISPR-Cas System
por: Kang, Kyungmin, et al.
Publicado: (2022)

Application of Artificial Intelligence in Pathology: Trends and Challenges
por: Kim, Inho, et al.
Publicado: (2022)

In vivo characterization of the physicochemical properties of TLR agonist delivery that enhance vaccine immunogenicity
por: Lynn, Geoffrey M., et al.
Publicado: (2015)

A TLR4 agonist liposome formulation effectively stimulates innate immunity and enhances protection from bacterial infection
por: Hedges, Jodi F., et al.
Publicado: (2023)

Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses
por: Milicic, Anita, et al.
Publicado: (2012)

Liposome-Based Co-Immunotherapy with TLR Agonist and CD47-SIRPα Checkpoint Blockade for Efficient Treatment of Colon Cancer
por: Chang, Rui, et al.
Publicado: (2023)

Synergistic Induction of Interferon α through TLR-3 and TLR-9 Agonists Identifies CD21 as Interferon α Receptor for the B Cell Response
por: Kim, Dhohyung, et al.
Publicado: (2013)

Development of Adamantane-Conjugated TLR7/8 Agonists for Supramolecular Delivery and Cancer Immunotherapy
por: Rodell, Christopher B., et al.
Publicado: (2019)

Differential Response of Gestational Tissues to TLR3 Viral Priming Prior to Exposure to Bacterial TLR2 and TLR2/6 Agonists
por: Rasheed, Zahirrah B. M., et al.
Publicado: (2020)

Contrast media mimicking subarachnoid hemorrhage after intrathecal injection in a patient with Creutzfeldt-Jakob disease
por: Kim, Taegyun
Publicado: (2022)

Contrast media mimicking subarachnoid hemorrhage after intrathecal injection in a patient with Creutzfeldt-Jakob disease
por: Kim, Taegyun
Publicado: (2022)

Herd immunity: challenges and the way forward in Korea
por: Oh, Jiyoung, et al.
Publicado: (2021)

Hybrid material of structural DNA with inorganic compound: synthesis, applications, and perspective
por: Shin, Seung Won, et al.
Publicado: (2020)

Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy
por: Bremer, Paul T., et al.
Publicado: (2014)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

NOD2 Agonist Promotes the Production of Inflammatory Cytokines in VSMC in Synergy with TLR2 and TLR4 Agonists
por: Sun, Jinghua, et al.
Publicado: (2012)

Ultrasound-Responsive Liposomes for Targeted Drug Delivery Combined with Focused Ultrasound
por: Kim, Yoon-Seok, et al.
Publicado: (2022)

High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+/regulatory T-cell infiltration
por: Kim, Sehui, et al.
Publicado: (2022)

Liposomal delivery of gene therapy for ovarian cancer: a systematic review
por: Son, Jin Sung, et al.
Publicado: (2023)

Mucinous Cystadenoma of the Testis: A Case Report with Immunohistochemical Findings
por: Kim, Gilhyang, et al.
Publicado: (2017)

A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity
por: Sato-Kaneko, Fumi, et al.
Publicado: (2020)

Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016)

Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy
por: Heo, Min Beom, et al.
Publicado: (2015)

Comparison of EI-GC-MS/MS, APCI-LC-MS/MS, and ESI-LC-MS/MS for the Simultaneous Analysis of Nine Nitrosamines Eluted from Synthetic Resins into Artificial Saliva and Health Risk Assessment
por: Kim, Hyungsoo, et al.
Publicado: (2021)

Comparison of human B cell activation by TLR7 and TLR9 agonists
por: Hanten, John A, et al.
Publicado: (2008)

Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists
por: Cheng, Kui, et al.
Publicado: (2015)

Trial Watch: experimental TLR7/TLR8 agonists for oncological indications
por: Frega, Giorgio, et al.
Publicado: (2020)

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
por: Kim, Geun-Tae, et al.
Publicado: (2009)

Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer’s Disease with Prolonged Sleep Latency
por: Um, Yoo Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gl01n6bu51i6mcuru8rv8attnc